These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19371188)

  • 21. Low-density lipoprotein cholesterol-independent effects of statins on coronary artery disease.
    Takagi H; Umemoto T
    Am J Cardiol; 2011 Jan; 107(2):336. PubMed ID: 21211613
    [No Abstract]   [Full Text] [Related]  

  • 22. Initiating statins in the elderly: the evolving challenge.
    Walker DB; Jacobson TA
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):182-7. PubMed ID: 18316955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin use and prognosis in patients with advanced heart failure.
    Martínez-Sellés M; Domínguez M; Martínez E; García Fernández MA; García E
    Int J Cardiol; 2007 May; 118(1):135-7. PubMed ID: 16949689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins and mortality.
    Muntwyler J; Gutzwiller F
    Eur Heart J; 2002 Feb; 23(3):183-4. PubMed ID: 11792128
    [No Abstract]   [Full Text] [Related]  

  • 25. Lipid management after acute coronary syndrome.
    Schwartz GG
    Curr Opin Lipidol; 2007 Dec; 18(6):626-32. PubMed ID: 17993807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Celik M; Celik T
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):253; author reply 253-4. PubMed ID: 19520663
    [No Abstract]   [Full Text] [Related]  

  • 27. Reassessing the validity of surrogate markers of drug efficacy in the treatment of coronary artery disease.
    Colatsky TJ
    Curr Opin Investig Drugs; 2009 Mar; 10(3):239-44. PubMed ID: 19333881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peri-operative statin update for non-cardiac surgery. Part I: The effects of statin therapy on atherosclerotic disease and lessons learnt from statin therapy in medical (non-surgical) patients.
    Biccard BM
    Anaesthesia; 2008 Jan; 63(1):52-64. PubMed ID: 18086071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 30. Who does not need a statin: too late in end-stage renal disease or heart failure?
    Laufs U; Custodis F; Böhm M
    Heart; 2008 Sep; 94(9):1138-40. PubMed ID: 18703694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of aggressive statin therapy.
    Conn Med; 2005; 69(6):339-41. PubMed ID: 16184860
    [No Abstract]   [Full Text] [Related]  

  • 32. Still without impact on adverse post-operative outcomes: pre-operative statin therapy in patients undergoing cardiac surgery.
    Hansel J; Simon P
    Eur Heart J; 2008 Oct; 29(19):2444; author reply 2444-5. PubMed ID: 18676398
    [No Abstract]   [Full Text] [Related]  

  • 33. The power of statins: aggressive lipid lowering.
    Jones PH
    Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Muscle-sparing' statins: preclinical profiles and future clinical use.
    Pfefferkorn JA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):245-52. PubMed ID: 19333882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Statins with a perspective of lifelong therapy].
    Ertaş FS
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statin therapy is beneficial for the prevention of atrial fibrillation in patients with coronary artery disease: a meta-analysis.
    Zhou X; Du JL; Yuan J; Chen YQ
    Eur J Pharmacol; 2013 May; 707(1-3):104-11. PubMed ID: 23524091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of clinical trial data reaffirms safety of statin therapy.
    Gotto AM
    Am J Manag Care; 2002 Jan; Suppl():2, 4. PubMed ID: 11833452
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intensive lipid lowering statin therapy immediately after acute coronary syndrome].
    Kovanen PT; Pentikäinen MO
    Duodecim; 2005; 121(10):1029-32. PubMed ID: 15999505
    [No Abstract]   [Full Text] [Related]  

  • 39. Which statin?
    Med Lett Drugs Ther; 2008 Apr; 50(1284):29-31. PubMed ID: 18425054
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcomes of patients discharged from pharmacy-managed cardiovascular disease management.
    Olson KL; Delate T; Rasmussen J; Humphries TL; Merenich JA;
    Am J Manag Care; 2009 Aug; 15(8):497-503. PubMed ID: 19670953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.